Successful robot‑assisted minimally invasive surgery for scirrhous gastric conduit cancer after esophagectomy: A case report

Okamoto,Koichi; Sannomiya,Yuta; Furuse,Koki; Maruyama,Kaori; Nishiki,Hisashi; Hashimoto,Akifumi; Kaida,Daisuke; Miyata,Takashi; Tsuji,Toshikatsu; Fujita,Hideto; Inaki,Noriyuki; Kinami,Shinichi; Ninomiya,Itasu; Takamura,Hiroyuki

doi:10.3892/ol.2025.15083

Successful robot‑assisted minimally invasive surgery for scirrhous gastric conduit cancer after esophagectomy: A case report

Authors:
- Koichi Okamoto
- Yuta Sannomiya
- Koki Furuse
- Kaori Maruyama
- Hisashi Nishiki
- Akifumi Hashimoto
- Daisuke Kaida
- Takashi Miyata
- Toshikatsu Tsuji
- Hideto Fujita
- Noriyuki Inaki
- Shinichi Kinami
- Itasu Ninomiya
- Hiroyuki Takamura
View Affiliations

Affiliations: Department of General and Digestive Surgery, Kanazawa Medical University Hospital, Kahoku, Ishikawa 920‑0293, Japan, Department of Gastrointestinal Surgery, Kanazawa University Hospital, Kanazawa, Ishikawa 920‑8641, Japan, Department of Surgery, Fukui Prefectural Hospital, Fukui, Fukui 910‑0846, Japan
Published online on: May 12, 2025 https://doi.org/10.3892/ol.2025.15083
Article Number: 337
Copyright: © Okamoto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Patients with reconstructed gastric conduit cancer following esophageal cancer surgery can be treated through gastric conduit resection and regional lymph node dissection for pathological R0 resection. However, these procedures are difficult owing to the adhesions and scars around the gastric conduit and anatomical irregularities. To the best of our knowledge, robotic resection for scirrhous gastric conduit cancer occurring along almost the entire reconstructed gastric conduit has not been reported in the literature to date. The present study report the case of a 69‑year‑old man who underwent radical robot‑assisted surgery for advanced gastric conduit cancer along most of the gastric conduit with regional lymph node metastases. The patient had previously undergone robot‑assisted thoracoscopic esophagectomy and posterior mediastinal gastric conduit reconstruction for thoracic esophageal cancer at another hospital. Subsequently, 5 years later, the patient underwent esophagogastroduodenoscopy for a passage disorder, during which an elevated lesion with severe stenosis was found at the esophagogastric anastomosis, along with mucosal irregularity along the reconstructed gastric conduit that was then pathologically diagnosed as poorly differentiated adenocarcinoma. Thereafter, the patient was referred to Kanazawa Medical University Hospital (Kahoku, Japan) where he underwent robotic intrathoracic surgery. Forceps manipulations under a three‑dimensional magnified view were conducted to dissect the adhesions around the lung, chest wall, tracheal membranous portion and reconstructed gastric conduit. Curative total remnant gastrectomy with lymph node dissection and digestive‑tract reconstruction using a pedicled jejunum were conducted without severe intraoperative injuries. Pathological analysis of the resected specimen indicated scirrhous gastric conduit cancer originating along the gastric conduit with marked full‑thickness fibrosis and clusters of adenocarcinoma cells. No obvious cancer remnants were found on the dissected surface of the subserous layer of the gastric conduit. After postoperative adjuvant chemotherapy with oral tegafur/gimeracil/oteracil and intravenous docetaxel for 4 months, the patient was alive without recurrence at 9 months postoperatively.

View Figures

View References

1	Chen SC, Teng CJ, Hu YW, Yeh CM, Hung MH, Hu LY, Ku FC, Tzeng CH, Chiou TJ, Chen TJ and Liu CJ: Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: A nationwide population-based study. PLoS One. 10:e01163842015. View Article : Google Scholar : PubMed/NCBI
2	Cui Y, Ren W, Du X, Yang L and Tan B: Research progress of multiple primary malignancies associated with esophageal cancer. Cancer Control. 30:107327482311766412023. View Article : Google Scholar : PubMed/NCBI
3	Baba Y, Ishimoto T, Kurashige J, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M and Baba H: Epigenetic field cancerization in gastrointestinal cancers. Cancer Lett. 375:360–366. 2016. View Article : Google Scholar : PubMed/NCBI
4	Chen D, Fan N, Mo J, Wang W, Wang R, Chen Y, Hu J and Wen Z: Multiple primary malignancies for squamous cell carcinoma and adenocarcinoma of the esophagus. J Thorac Dis. 11:3292–3301. 2019. View Article : Google Scholar : PubMed/NCBI
5	Maeda M, Moro H and Ushijima T: Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: Aberrant DNA methylation pathway. Gastric Cancer. 20:8–15. 2017. View Article : Google Scholar : PubMed/NCBI
6	Oki E, Morita M, Toh Y, Kimura Y, Ohgaki K, Sadanaga N, Egashira A, Kakeji Y, Tsujitani S and Maehara Y: Gastric cancer in the reconstructed gastric tube after radical esophagectomy: A single-center experience. Surg Today. 41:966–969. 2011. View Article : Google Scholar : PubMed/NCBI
7	Lee GD, Kim YH, Choi SH, Kim HR, Kim DK and Park SI: Gastric conduit cancer after oesophagectomy for oesophageal cancer: Incidence and clinical implications. Eur J Cardiothorac Surg. 45:899–903. 2014. View Article : Google Scholar : PubMed/NCBI
8	Mukasa M, Takedatsu H, Matsuo K, Sumie H, Yoshida H, Hinosaka A, Watanabe Y, Tsuruta O and Torimura T: Clinical characteristics and management of gastric tube cancer with endoscopic submucosal dissection. World J Gastroenterol. 21:919–925. 2015. View Article : Google Scholar : PubMed/NCBI
9	Shirakawa Y, Noma K, Maeda N, Ninomiya T, Tanabe S, Kikuchi S, Kuroda S, Nishizaki M, Kagawa S, Kawahara Y, et al: Clinical characteristics and management of gastric tube cancer after esophagectomy. Esophagus. 15:180–189. 2018. View Article : Google Scholar : PubMed/NCBI
10	Gentile D, Riva P, Da Roit A, Basato S, Marano S and Castoro C: Gastric tube cancer after esophagectomy for cancer: A systematic review. Dis Esophagus. 32:doz0492019. View Article : Google Scholar : PubMed/NCBI
11	Hirayama Y, Fujisaki J, Yoshimizu S, Horiuchi Y, Yoshio T, Ishiyama A, Hirasawa T, Imamura Y, Mine S, Watanabe M and Tsuchida T: Efficacy and safety of endoscopic resection for gastric tube cancer after surgical resection of esophageal squamous cell carcinoma. Esophagus. 16:194–200. 2019. View Article : Google Scholar : PubMed/NCBI
12	Urabe M, Haruta S, Tanaka M, Yago A, Ohkura Y, Tanaka T, Hoteya S, Ueno M and Udagawa H: Management and outcomes of resectable gastric conduit cancer: A retrospective comparative study of 51 cases. Langenbecks Arch Surg. 406:1433–1441. 2021. View Article : Google Scholar : PubMed/NCBI
13	Ota M, Morita M, Ikebe M, Nakashima Y, Yamamoto M, Matsubara H, Kakeji Y, Doki Y and Toh Y: Clinicopathological features and prognosis of gastric tube cancer after esophagectomy for esophageal cancer: A nationwide study in Japan. Esophagus. 19:384–392. 2022. View Article : Google Scholar : PubMed/NCBI
14	Toyoshima Y, Narumiya K, Kudo K, Egawa H and Hosoda K: Comparative analysis of the outcomes of gastrectomy vs. endoscopic mucosal resection or endoscopic submucosal dissection for the treatment of gastric tube cancer after esophagectomy. Glob Health Med. 5:40–46. 2023. View Article : Google Scholar : PubMed/NCBI
15	de Groot EM, van der Horst S, Kingma BF, Goense L, van der Sluis PC, Ruurda JP and van Hillegersberg R: Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open esophagectomy: Long-term follow-up of a randomized clinical trial. Dis Esophagus. 33:doaa0792020. View Article : Google Scholar : PubMed/NCBI
16	Mederos MA, de Virgilio MJ, Shenoy R, Ye L, Toste PA, Mak SS, Booth MS, Begashaw MM, Wilson M, Gunnar W, et al: Comparison of clinical outcomes of robot-assisted, video-assisted, and open esophagectomy for esophageal cancer: A systematic review and meta-analysis. JAMA Netw Open. 4:e21292282021. View Article : Google Scholar : PubMed/NCBI
17	Ninomiya I, Okamoto K, Yamaguchi T, Saito H, Terai S, Moriyama H, Kinoshita J and Fushida S: Optimization of robot-assisted thoracoscopic esophagectomy in the lateral decubitus position. Esophagus. 18:482–488. 2021. View Article : Google Scholar : PubMed/NCBI
18	Fujita T, Sato K, Ozaki A, Akutsu T, Fujiwara H, Kojima T and Daiko H: Propensity-matched analysis of the short-term outcome of robot-assisted minimally invasive esophagectomy versus conventional thoracoscopic esophagectomy in thoracic esophageal cancer. World J Surg. 46:1926–1933. 2022. View Article : Google Scholar : PubMed/NCBI
19	Zhang Y, Dong D, Cao Y, Huang M, Li J, Zhang J, Lin J, Sarkaria IS, Toni L, David R, et al: Robotic versus conventional minimally invasive esophagectomy for esophageal cancer: A meta-analysis. Ann Surg. 278:39–50. 2023. View Article : Google Scholar : PubMed/NCBI
20	Japanese Gastric Cancer Association, . Japanese Classification of Gastric Carcinoma. Kanehara & Co., Ltd.; Tokyo: pp. 10–24. 2017
21	Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, et al: Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer: Interim analysis of JACCRO GC-07, a randomized controlled trial. J Clin Oncol. 37:1296–1304. 2019. View Article : Google Scholar : PubMed/NCBI
22	Kakeji Y, Yoshida K, Kodera Y, Kochi M, Sano T, Ichikawa W, Lee SW, Shibahara K, Shikano T, Kataoka M, et al: Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07. Gastric Cancer. 25:188–196. 2022. View Article : Google Scholar : PubMed/NCBI
23	van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens LAA, Joore HCA, Kroese CC, Haj Mohammad N, Mook S, Vleggaar FP, et al: Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: A randomized controlled trial. Ann Surg. 269:621–630. 2019. View Article : Google Scholar : PubMed/NCBI
24	Perry R, Barbosa JP, Perry I and Barbosa J: Short-term outcomes of robot-assisted versus conventional minimally invasive esophagectomy for esophageal cancer: A systematic review and meta-analysis of 18,187 patients. J Robot Surg. 18:1252024. View Article : Google Scholar : PubMed/NCBI
25	Dalager T, Jensen PT, Eriksen JR, Jakobsen HL, Mogensen O and Sogaard K: Surgeons' posture and muscle strain during laparoscopic and robotic surgery. Br J Surg. 107:756–766. 2020. View Article : Google Scholar : PubMed/NCBI
26	Zong L, Seto Y, Aikou S and Takahashi T: Efficacy evaluation of subtotal and total gastrectomies in robotic surgery for gastric cancer compared with that in open and laparoscopic resections: A meta-analysis. PLoS One. 9:e1033122014. View Article : Google Scholar : PubMed/NCBI
27	Sheng S, Zhao T and Wang X: Comparison of robot-assisted surgery, laparoscopic-assisted surgery, and open surgery for the treatment of colorectal cancer: A network meta-analysis. Medicine. 97:e118172018. View Article : Google Scholar : PubMed/NCBI
28	Warner S, Chang YH, Paripati H, Ross H, Ashman J, Harold K, Day R, Stucky CC, Rule W and Jaroszewski D: Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Thorac Surg. 97:439–445. 2014. View Article : Google Scholar : PubMed/NCBI
29	Tagkalos E, van der Sluis PC, Berlth F, Poplawski A, Hadzijusufovic E, Lang H, van Berge Henegouwen MI, Gisbertz SS, Müller-Stich BP, Ruurda JP, et al: Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial). BMC Cancer. 21:10602021. View Article : Google Scholar : PubMed/NCBI
30	Defize IL, van der Horst S, Ruurda JP and van Hillegersberg R: ASO author reflections: Preoperative selection of cT4b esophageal cancer patients who benefit from a salvage robot-assisted minimally invasive esophagectomy (RAMIE). Ann Surg Oncol. 28:2739–2740. 2021. View Article : Google Scholar : PubMed/NCBI
31	Alhossaini RM, Altamran AA, Cho M, Roh CK, Seo WJ, Choi S, Son T, Kim HI and Hyung WJ: Lower rate of conversion using robotic-assisted surgery compared to laparoscopy in completion total gastrectomy for remnant gastric cancer. Surg Endosc. 34:847–852. 2020. View Article : Google Scholar : PubMed/NCBI
32	Ma FH, Liu H, Ma S, Li Y and Tian YT: Current controversies in treating remnant gastric cancer: Are minimally invasive approaches feasible? World J Clin Cases. 7:3384–3393. 2019. View Article : Google Scholar : PubMed/NCBI
33	Toh Y, Kitagawa Y, Kuwano H, Kusano M, Oyama T, Muto M, Kato H, Takeuchi H, Doki Y, Naomoto Y, et al: A nation-wide survey of follow-up strategies for esophageal cancer patients after a curative esophagectomy or a complete response by definitive chemoradiotherapy in Japan. Esophagus. 13:173–181. 2015. View Article : Google Scholar
34	Nakanoko T, Morita M, Nakashima Y, Ota M, Ikebe M, Yamamoto M, Booka E, Takeuchi H, Kitagawa Y, Matsubara H, et al: Nationwide survey of the follow-up practices for patients with esophageal carcinoma after radical treatment: Historical changes and future perspectives in Japan. Esophagus. 19:69–76. 2022. View Article : Google Scholar : PubMed/NCBI
35	Nonaka S, Oda I, Sato C, Abe S, Suzuki H, Yoshinaga S, Hokamura N, Igaki H, Tachimori Y, Taniguchi H, et al: Endoscopic submucosal dissection for gastric tube cancer after esophagectomy. Gastrointest Endosc. 79:260–270. 2014. View Article : Google Scholar : PubMed/NCBI
36	Kise Y, Kijima H, Shimada H, Tanaka H, Kenmochi T, Chino O, Tajima T and Makuuchi H: Gastric tube cancer after esophagectomy for esophageal squamous cell cancer and its relevance to Helicobacter pylori. Hepatogastroenterology. 50:408–411. 2003.PubMed/NCBI
37	Dixon MF, Mapstone NP, Neville PM, Moayyedi P and Axon AT: Bile reflux gastritis and intestinal metaplasia at the cardia. Gut. 51:351–355. 2002. View Article : Google Scholar : PubMed/NCBI
38	Palmes D, Weilinghoff M, Colombo-Benkmann M, Senninger N and Bruewer M: Effect of pyloric drainage procedures on gastric passage and bile reflux after esophagectomy with gastric conduit reconstruction. Langenbecks Arch Surg. 392:135–141. 2007. View Article : Google Scholar : PubMed/NCBI
39	Bamba T, Kosugi S, Takeuchi M, Kobayashi M, Kanda T, Matsuki A and Hatakeyama K: Surveillance and treatment for second primary cancer in the gastric tube after radical esophagectomy. Surg Endosc. 24:1310–1317. 2010. View Article : Google Scholar : PubMed/NCBI
40	Agnes A, Estrella JS and Badgwell B: The significance of a nineteenth century definition in the era of genomics: linitis plastica. World J Surg Oncol. 15:1232017. View Article : Google Scholar : PubMed/NCBI
41	Kodera Y, Yoshida K, Kochi M, Sano T, Ichikawa W, Kakeji Y, Sunakawa Y, Takeuchi M and Fujii M: Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in stage III gastric cancer: A final report of the JACCRO GC-07 study. Gastric Cancer. 26:1063–1068. 2023. View Article : Google Scholar : PubMed/NCBI
42	Koyanagi K, Ozawa S, Ando N, Shih CH, Nakamura E, Takeuchi H, Hayashi K and Kitajima M: Case report: Metachronous early gastric carcinoma in a reconstructed gastric tube after radical operation for oesophageal carcinoma. J Gastroenterol Hepatol. 13:311–315. 1998. View Article : Google Scholar : PubMed/NCBI
43	Fujisawa K, Ueno M, Okamoto K, Shimoyama H, Ohkura Y, Haruta S and Udagawa H: Successful robot-assisted surgery for advanced metachronous cancer in a gastric conduit after esophagectomy: A case report. Ann Thorac Cardiovasc Surg. 30:23–00202. 2024. View Article : Google Scholar : PubMed/NCBI